MarketPulse — Real-Time Financial News & Market Analysis

Latest News

15,542 articles
Tue, Mar 10
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Ramaco Resources Faces Securities Class Action Over Brook Mine Misstatements

Rosen Law Firm alerts investors in $METC securities class action with March 31, 2026 lead plaintiff deadline, citing materially false statements about mining operations.
METCMETCBMETCIMETCZsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

PennyMac Stock Plunges 33% After Q4 Results Disappoint; Class Action Probe Launched

PennyMac Financial Services stock crashed 33.3% following weak Q4 2025 earnings, prompting securities investigation into alleged misleading disclosures.
PFSIsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Justin Pope

Apple's $599 MacBook Neo Signals Aggressive Push Into Budget Laptop Market

Apple launched MacBook Neo at $599, targeting untapped budget segment. Mac products represent just 10% of $305B hardware sales, offering significant growth potential.
GOOGGOOGLAAPLvaluationmarket expansion
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Apollo Global Management Faces Securities Class Action Over Epstein Ties Disclosure

Rosen Law Firm sued Apollo Global Management for allegedly concealing executive ties to Jeffrey Epstein. Investors have until May 1, 2026 to join.
APOAPOSAPOpAsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Geoffrey Seiler

High-Yield Midstream Energy: Three Stocks Offering 5.9%-8.6% Returns

Energy Transfer, Enterprise Products Partners, and Western Midstream Partners offer 5.9%-8.6% dividend yields backed by critical energy infrastructure and AI data center demand.
EPDETETpIOXYOXY.WS+2passive incomedividend yield
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Soleno Therapeutics Hit With Class Action Over VYKAT Launch Failures and Safety Disclosures

$SLNO faces securities lawsuit alleging misleading safety claims for hyperphagia drug VYKAT XR. Stock crashed 40% after short seller report and management admissions of launch disruptions.
SLNOsecurities class actionclinical trial
The Motley FoolThe Motley Fool··Joe Tenebruso

3D Systems Stock Surges 27% on Path to Profitability, Strong Sector Growth

$DDD stock jumped 27.30% after reporting strong Q4 revenue growth and significant cost savings, signaling progress toward profitability.
DDDaerospace and defenseprofitability
The Motley FoolThe Motley Fool··Geoffrey Seiler

Berkshire's $373B Cash Pile: Is Patience a Virtue or a Missed Opportunity?

Berkshire Hathaway's $373.3 billion cash stockpile and 13-quarter selling streak raise questions about whether CEO Greg Abel's patient capital strategy is prudent or costly in tech-dominated markets.
AXPBACBACpBBACpEBACpK+19valuationshare buyback
The Motley FoolThe Motley Fool··Lyle Daly

Alphabet Poised to Outpace Nvidia as AI Boom Matures, Analysts Say

Alphabet's diversified revenue model positions it for superior long-term returns versus Nvidia, whose 91% data center reliance creates vulnerability to AI spending cycles.
NVDAAMDMETAGOOGGOOGLdata centerrevenue diversification
GlobeNewswire Inc.GlobeNewswire Inc.··Oriental Rise Holdings Limited

Oriental Rise Bets $23M on Solar-Tea Hybrid: 50MW Agro-Solar Project Signals Shift

Oriental Rise partners with Shandong Yiyang on 50MW agro-solar project across tea plantations, investing RMB165 million over 20 years.
ORISstrategic partnershipsustainability
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Calidi Biotherapeutics Raises $6M in Public Offering, Exercises Full Warrant Overallotment

Calidi Biotherapeutics closed a $6 million underwritten public offering, issuing 12.1 million shares and Series J, K, L warrants with $0.50 exercise prices.
CLDIwarrantspublic offering
The Motley FoolThe Motley Fool··Johnny Rice

Can AST SpaceMobile Justify Its $39B Valuation on $54M Revenue?

AST SpaceMobile trades at 382x sales with major carrier partnerships. Massive upside potential offset by execution risk and minimal current operations.
VZASTSTTBBTpA+3space technologyexecution risk
BenzingaBenzinga··Business Wire

Nektar Therapeutics Faces Securities Fraud Lawsuit Over Misleading Trial Claims

Schall Law Firm seeks investors in class action against $NKTR over alleged false statements regarding REZOLVE-AA trial enrollment and integrity.
NKTRsecurities fraudclass action lawsuit
Mon, Mar 9
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

GSI Technology Stock Plunges 14.2% Amid Securities Fraud Probe Over AI Claims

The Rosen Law Firm investigates alleged securities fraud at GSI Technology ($GSIT) following a 14.2% stock decline tied to misrepresented AI chip capabilities.
SANBCSGSITsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Percepta Sweeps 2026 Stevie Awards, Signals Leadership Shift in Auto Customer Experience

Percepta wins seven Stevie Awards across all entered categories, signaling customer experience leadership as new president replaces departing Karen Gurganious.
FFpBFpCFpDTTECleadership transitionautomotive industry
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Santander Faces Securities Investigation After UK Mortgage Collapse Triggers 7.6% Stock Plunge

Banco Santander faces securities investigation after Reuters exposé reveals undisclosed losses from UK mortgage provider collapse, triggering 7.6% ADS decline.
SANsecurities fraudclass action lawsuit
BenzingaBenzinga··Prnewswire

Kansas City Life Swings to Q4 Profit as Insurance Revenues Surge

Kansas City Life returned to Q4 profitability with $1.0M net income versus $14.0M loss last year. Adjusted 2025 earnings exclude litigation charges.
KCLIearningsnet income
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Telix Pharma's TLX591-Tx Clears Phase 3 Safety Hurdle, Paves Path to Expansion

Telix Pharmaceuticals' TLX591-Tx meets Phase 3 safety objectives in prostate cancer trial, advancing toward U.S. expansion with FDA.
TLXPhase 3 clinical trialFDA approval
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Pepeto Presale Hits $7.8M as Bitcoin Rallies on Peace Signals; Whales Accumulate

Pepeto presale surges to $7.857M as Bitcoin rallies to $68,000; whale wallets accumulate $23B in BTC during market weakness.
AMJBJPMJPMpCJPMpDJPMpJ+4Pepeto presalecryptocurrency
GlobeNewswire Inc.GlobeNewswire Inc.··The Rosen Law Firm

Barclays Plummets on £600M Market Financial Solutions Exposure

Barclays stock dropped over 6% following disclosure of £600 million exposure to failed UK mortgage lender Market Financial Solutions Ltd.
BCSsecurities fraudclass action lawsuit